Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 26% ± 5% | |
microglial cell | 4 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1471.45 | 1445 / 1445 | 100% | 15.58 | 183 / 183 |
breast | 100% | 1473.30 | 459 / 459 | 100% | 15.37 | 1115 / 1118 |
intestine | 100% | 1367.98 | 966 / 966 | 99% | 13.02 | 524 / 527 |
bladder | 100% | 1115.57 | 21 / 21 | 99% | 11.78 | 500 / 504 |
thymus | 100% | 1826.49 | 653 / 653 | 99% | 13.81 | 599 / 605 |
kidney | 100% | 1398.93 | 89 / 89 | 99% | 11.36 | 892 / 901 |
lung | 99% | 1211.75 | 572 / 578 | 100% | 12.77 | 1155 / 1155 |
pancreas | 100% | 896.35 | 328 / 328 | 99% | 11.26 | 176 / 178 |
prostate | 100% | 1506.01 | 245 / 245 | 99% | 11.29 | 496 / 502 |
ovary | 100% | 1087.58 | 180 / 180 | 98% | 7.67 | 423 / 430 |
stomach | 99% | 915.17 | 355 / 359 | 99% | 12.52 | 284 / 286 |
uterus | 100% | 1169.75 | 170 / 170 | 98% | 10.44 | 450 / 459 |
brain | 96% | 517.97 | 2528 / 2642 | 100% | 10.18 | 704 / 705 |
skin | 100% | 1387.91 | 1807 / 1809 | 94% | 9.61 | 446 / 472 |
adrenal gland | 100% | 1726.73 | 258 / 258 | 94% | 7.15 | 217 / 230 |
liver | 100% | 1256.24 | 226 / 226 | 87% | 5.25 | 354 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.82 | 29 / 29 |
spleen | 100% | 2073.82 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1193.94 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 715.65 | 1307 / 1335 | 0% | 0 | 0 / 0 |
muscle | 97% | 594.05 | 778 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 8.78 | 43 / 45 |
heart | 94% | 645.58 | 811 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 5.89 | 64 / 80 |
peripheral blood | 65% | 869.13 | 603 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006370 | Biological process | 7-methylguanosine mRNA capping |
GO_0032259 | Biological process | methylation |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004483 | Molecular function | mRNA (nucleoside-2'-O-)-methyltransferase activity |
Gene name | CMTR2 |
Protein name | Cap methyltransferase 2 Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (HMTr2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog) |
Synonyms | FTSJD1 AFT |
Description | FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that mediates mRNA cap2 2'-O-ribose methylation to the 5'-cap structure of mRNAs. Methylates the ribose of the second nucleotide of a m(7)GpppG-capped mRNA and small nuclear RNA (snRNA) (cap0) to produce m(7)GpppRmpNm (cap2). Recognizes a guanosine cap on RNA independently of its N(7) methylation status. Display cap2 methylation on both cap0 and cap1. Displays a preference for cap1 RNAs. . |
Accessions | H3BNZ8 H3BR19 ENST00000564183.1 ENST00000565850.1 ENST00000338099.9 H3BUK2 H3BTZ7 Q8IYT2 ENST00000563876.1 ENST00000567610.1 ENST00000434935.7 ENST00000568910.1 H3BS00 |